David John Blackbourn

Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom.

The Microbiology Society provides grants and prizes to its members. The non-profit company is based in London, UK. The society offers a range of resources to its members, and also provides information on how to use microbiology knowledge in roles outside of research. The website also includes information on accessibility. The British company was founded in 1945. The CEO is Peter Cotgreave.